Requests that the FDA declare that Mexiletine Hydrochloride Capsules 100 mg, 300 mg and 400 mg, is suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2026-P-0431
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jan 16, 2026No comment period